TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Clinical trial NCT00503529 · COMPLETED

Trial details

NCT number: NCT00503529
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Encephalitis, Tick-Borne

Start date: 2007-07-01
Primary completion: 2010-07-01
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.